Cinnarizine 20mg plus Dimenhydrinate 40mg: Uses and Contraindications
The fixed-dose combination of cinnarizine 20mg and dimenhydrinate 40mg is primarily indicated for the treatment of vertigo of central and/or peripheral vestibular origin, including symptoms such as dizziness, nausea, vomiting, and associated balance disturbances.
Primary Indications
This combination medication is specifically used for:
- Vestibular vertigo (both peripheral and central origin) 1, 2
- Acute vestibular syndrome with associated symptoms 1
- Inner ear disorders causing vertigo 3
- Vertigo-related symptoms including:
- Rotary sensation and dizziness
- Dystasia and walking unsteadiness
- Staggering and tendency to fall
- Nausea and vomiting
- Tinnitus 4
The combination has demonstrated superior efficacy compared to betahistine (the most widely prescribed anti-vertigo medication) in reducing vertigo symptoms, with significant improvement observable from the first week of treatment 5, 1.
Mechanism and Dosing
Standard dosing: One tablet (cinnarizine 20mg/dimenhydrinate 40mg) three times daily 5, 2
The combination works through complementary mechanisms: cinnarizine acts as a calcium channel blocker with antihistaminic properties, while dimenhydrinate provides H1-receptor antagonism with anticholinergic effects 3.
Absolute Contraindications
The following are strict contraindications per FDA labeling:
- Neonates (absolutely contraindicated) 6
- Known hypersensitivity to dimenhydrinate, cinnarizine, diphenhydramine, or 8-chlorotheophylline 6
- Products containing benzyl alcohol should not be used in premature infants or low birth weight infants due to fatal "Gasping Syndrome" risk 6
Relative Contraindications and Cautions
Use with extreme caution or avoid in:
- Prostatic hypertrophy - anticholinergic effects may worsen urinary retention 6
- Stenosing peptic ulcer or pyloroduodenal obstruction 6
- Bladder neck obstruction 6
- Narrow-angle glaucoma - anticholinergic effects contraindicated 6
- Bronchial asthma - may be aggravated 6
- Cardiac arrhythmias - use with caution 6
Pregnancy Considerations
While dimenhydrinate is considered a safe first-line antiemetic in pregnancy for nausea and vomiting 7, the specific fixed combination with cinnarizine lacks adequate safety data. H1-receptor antagonists like dimenhydrinate are ACOG-recommended for pregnancy-related nausea, but this recommendation applies to dimenhydrinate alone, not the fixed combination 7.
Critical Safety Warnings
Masking of ototoxicity: Dimenhydrinate can mask symptoms of ototoxicity when used with certain antibiotics, potentially allowing progression to irreversible hearing damage 6. Monitor carefully if concurrent ototoxic antibiotic use is necessary.
CNS depression: This combination impairs mental and physical abilities required for driving or operating machinery 6. Avoid alcohol and other CNS depressants due to additive effects 6.
Pediatric considerations: In children, antihistamines may cause paradoxical excitation rather than sedation, and in overdose can cause hallucinations, convulsions, or death 6. Use extreme caution in young children.
Elderly patients: Anticholinergic effects may cause confusion, oversedation, and increased fall risk. The combination should be used cautiously in this population 6.
Efficacy Evidence
The fixed combination demonstrated a 61% improvement in mean vertigo scores over 6 weeks in real-world practice 4, with 74.7% of patients achieving complete symptom resolution after 4 weeks compared to lower rates with comparators 2. The combination showed superiority over betahistine 16mg with better tolerability 5, 1.
Tolerability Profile
Adverse events are uncommon (3.7-6.9% reporting non-serious events), with most patients rating tolerability as "good" or "very good" (95-97.9%) 2, 4. The safety profile is favorable compared to alternative treatments, with lower discontinuation rates due to adverse effects 5.